Lifevantage (NASDAQ:LFVN) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Shares of Lifevantage Corporation (NASDAQ:LFVN) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.56 and traded as high as $5.72. Lifevantage shares last traded at $5.61, with a volume of 110,640 shares trading hands.

Analysts Set New Price Targets

Several equities analysts recently issued reports on LFVN shares. Loop Capital set a $5.00 price objective on Lifevantage in a research report on Thursday, February 5th. Lake Street Capital lowered shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a research note on Thursday, May 7th. Finally, Weiss Ratings lowered shares of Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.00.

Lifevantage Trading Up 4.5%

The firm has a market capitalization of $70.80 million, a PE ratio of 12.47 and a beta of 0.52. The business’s 50 day simple moving average is $4.80 and its two-hundred day simple moving average is $5.56.

Lifevantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $43.72 million during the quarter, compared to analysts’ expectations of $47.77 million. Lifevantage had a return on equity of 23.89% and a net margin of 2.94%. As a group, equities research analysts anticipate that Lifevantage Corporation will post 0.6 earnings per share for the current year.

Lifevantage Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a $0.05 dividend. This is a positive change from Lifevantage’s previous quarterly dividend of $0.05. The ex-dividend date is Monday, June 1st. This represents a $0.20 annualized dividend and a dividend yield of 3.6%. Lifevantage’s dividend payout ratio (DPR) is currently 40.00%.

Insider Activity at Lifevantage

In related news, Director Judd Dayton acquired 10,500 shares of Lifevantage stock in a transaction dated Monday, March 2nd. The stock was purchased at an average cost of $4.53 per share, for a total transaction of $47,565.00. Following the purchase, the director directly owned 80,359 shares of the company’s stock, valued at approximately $364,026.27. This trade represents a 15.03% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In the last ninety days, insiders acquired 34,252 shares of company stock valued at $157,940. Corporate insiders own 21.95% of the company’s stock.

Institutional Investors Weigh In On Lifevantage

Hedge funds and other institutional investors have recently modified their holdings of the stock. Capital Management Corp VA boosted its holdings in Lifevantage by 3.4% in the 4th quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock worth $13,149,000 after buying an additional 70,398 shares during the period. Renaissance Technologies LLC boosted its holdings in Lifevantage by 8.3% in the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock worth $5,685,000 after buying an additional 70,900 shares during the period. Wasatch Advisors LP boosted its holdings in Lifevantage by 6.6% in the 2nd quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after buying an additional 27,765 shares during the period. Geode Capital Management LLC boosted its holdings in Lifevantage by 106.1% in the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after buying an additional 126,274 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in Lifevantage by 305.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock worth $1,233,000 after buying an additional 150,785 shares during the period. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.